| Molecular formula | C78H111N21O19 |
|---|
| Molecular weight | 1646.8 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 16197727 |
|---|
What melanotan I is
Melanotan I is a synthetic peptide with the molecular formula C78H111N21O19 and a molecular weight of approximately 1646.8 g/mol (PubChem CID 16197727). It has no FDA-approved label, no DailyMed entry, and no assigned RxNorm identifier, meaning it is not a recognized prescription drug in the United States. This monograph reflects its status as an unapproved research compound rather than an approved medicine.
What the evidence shows
Public registries show no registered clinical trials for melanotan I at this time. There is no available trial sample data to summarize phases, designs, or outcomes. Because no trials are listed, no conclusions about safety or effect in humans can be drawn from registry data.
FAQ
No. Melanotan I has no FDA-approved label, no DailyMed listing, and no RxNorm identifier, which means it is not recognized as an approved prescription medication in the United States.
Public trial registries currently show no registered clinical trials for melanotan I. Without registered trials, there is no study data available to describe design, phase, or outcomes.
Melanotan I is a synthetic peptide with the molecular formula C78H111N21O19 and a molecular weight of about 1646.8 g/mol. It is catalogued in PubChem under CID 16197727.
No adverse event report data is currently available for melanotan I in the dataset reviewed. This means no pattern of reported reactions can be summarized at this time.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem CID 16197727
Updated 2026-11-07